Upcoming: High-Level Conference on the Value and Role of Incentives in Life Sciences
Date: 7 November 2023
Time: 12 pm to 4:30 pm
Venue: Brussels, Permanent Representation of the Czech Republic to the EU, Rue Caroly 15
Format: Hybrid (in-person and online)
Registration: for registration please use this link: https://1url.cz/YulmU, for more information on how to attend in person or to obtain a link to the webcast, please contact events@aifp.cz
The Association of Innovative Pharmaceutical Industry in cooperation with the national associations of the innovative industry of Sweden (Lif), Belgium (pharma.be) and Spain (Farmaindustria), with the support of the European Federation of Pharmaceutical Industries and Associations (EFPIA), under the kind auspices of the Ministry of Health of the Czech Republic, is organizing an international expert conference on the current issue of the reform of the European legislative framework for pharmaceuticals (the so-called General Pharmaceutical Legislation, GPL).
The proposal, adopted by the European Commission on 26 April 2023, aims to improve the availability of innovative therapeutics for European patients and to ensure the EU's global competitiveness in innovation. The document includes, among others, measures to simplify and speed up regulatory processes or calls for a reduction in the baseline period of Regulatory Data Protection (RDP).
The aim of the expert discussion is to find answers to 2 key questions:
- What role do various types of intellectual property rights (IPR) play in supporting innovation?
- Can the current form of the European Commission's proposal achieve its goals?
The content of the conference will focus in particular on:
- IPR and their role in terms of investment decision-making
- incentives for drug innovation and their comparison across continents
- the potential impact of the European Commission's proposal on the practical availability of innovative medicines for patients
Speakers:
- Sandra Gallina, Director-General, DG SANTE, European Commission
- Edita Hrdá, Ambassador, Head of the Czech Permanent Representation of the EU
- Dolors Montserrat, Member of the European Parliament
- Radka Maxová, Member of the European Parliament
- Jakub Dvořáček, Deputy Minister of Health of the Czech Republic
- Nathalie Moll, Director General, EFPIA
- Claus Runge, Senior Vice President and Global Head of Market Access, Public Affairs and Sustainability, Bayer
- Juan Yermo, Director General, Farmaindustria
- Julian Isla, Chief Scientific Officer, European Federation for Dravet Syndrome
- Charlotte Weyne, Senior Legal Counsel & European Policy Advisor, pharma.be
- Laetitia Szaller, General Counsel and Vice President of Corporate Development, AM-Pharma
- Elaine Cruikshank, Founding Partner, Acumen
The conference is co-organized by:
The event was supported by:
The event takes place under the kind auspices of:
Agenda_Value and Role of Incentives in Life Sciences